EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5 Recall
EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5
FDA recall Class II
Ongoing
FDA lists this Class II recall for EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1480-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jan 21, 2026
- FDA report date
- Mar 11, 2026
- Quantity in commerce
- 7
- Distribution
- See key details
- FDA cause
- Process control
What is being recalled?
EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5
Affected model & UDI checker
Search the exact identifiers published for Z-1480-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| VTICM5 | EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5 | Check source notice | Not specified |
| Not specified | EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5 | Check source notice | 00840311304363 |
FDA code information
UDI-DI: 00840311304363. Expiration Date: 2027-11-30 Serial Numbers: T2286964, T2286971, T2286973, T2286979, T2286980, T2286981, T2286988
Why was this product recalled?
Toric Implantable Collamer for correction/reduction of myopia in phakic eyes with astigmatism were labeled as 12.1 mm length but are 12.6 mm length lenses, so there is the potential for excessive vault, which may cause: Significant reduction of irido-corneal angles, Significant shallowing of anterior chamber, Patient discomfort, Elevated IOP/Angle closure, Unreactive pupil, Lens exchange/removal.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Staar Surgical AG take?
On 1/21/2026, a Field Safety Notice was mailed to customers who were asked to do the following: 1. If any of the devices identified in the Field Safety Notice Return Response form have not already been implanted, remove them from your inventory and quarantine the product. 2. Complete the Field Safety Notice Return Response form indicating if each device has been implanted or is in your possession. 3. Complete and email the Field Safety Notice Return Response form to [email protected]. 5. Return affected devices to the firm. Should you have any questions, contact the firm's Representative or Customer Service at [email protected] or by phone at +41323328888 Monday through Friday, 8:00am to 5:00pm CET.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1480-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology